Ekaterina Kalashnikova

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy”.

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.04.008

N/A

0.777DataRank · unranked

177 citations

Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova +26 more

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Nature Medicine(2024)10.1038/s41591-024-03249-3

N/A

0.648DataRank · unranked

74 citations

Olga I. Isaeva, Manon de Graaf, Robbert C. A. M. Gielen, Noor A. M. Bakker, Adrianne L. Rolfes +33 more

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

npj Breast Cancer(2021)10.1038/s41523-021-00239-3

N/A

0.598DataRank · unranked

53 citations

Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart +12 more

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1253629

N/A

0.449DataRank · unranked

19 citations

Narek Shaverdian, Jordan Eichholz, L.B. Kratochvil, Megan McCune, Yonina R. Murciano‐Goroff +27 more

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

Nature Communications(2025)10.1038/s41467-025-65432-5

N/A

0.292DataRank · unranked

6 citations

Nayelis A. Manon, Denise M. Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Rosalyn W. Sayaman +20 more

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

BMC Cancer(2024)10.1186/s12885-024-12689-6

N/A

0DataRank · unranked

26 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Monitoring Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Using Circulating Tumor DNA

Research Square(2024)10.21203/rs.3.rs-4104393/v1

N/A

0DataRank · unranked

0 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies

medRxiv(2025)10.1101/2025.08.23.25332468

N/A

0DataRank · unranked

0 citations

Alexander Chih-Chieh Chang, Fangyuan Chen, Shannon Puhalla, Julia Foldi, Hunter Waltermire +21 more